Cite
HARVARD Citation
Xie, M. et al. (2021). Neddylation inhibitor MLN4924 has anti‐HBV activity via modulating the ERK‐HNF1α‐C/EBPα‐HNF4α axis. Journal of cellular and molecular medicine. 25 (2), pp. 840-854. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xie, M. et al. (2021). Neddylation inhibitor MLN4924 has anti‐HBV activity via modulating the ERK‐HNF1α‐C/EBPα‐HNF4α axis. Journal of cellular and molecular medicine. 25 (2), pp. 840-854. [Online].